Session date: May 22, 2023
Biologic treatments have been beneficial for many severe asthma patients, but many others continue to have debilitating chronic dyspnea, exacerbations and/or medication side effects. Recent advances in asthma biology and in technology have provided exciting opportunities to improve personalized severe asthma management. Leveraging insights from the NHLBI Precise network and ICAN meeting, we will provide an update on the latest insights in this field.
Biologic treatments have been beneficial for many severe asthma patients, but many others continue to have debilitating chronic dyspnea, exacerbations and/or medication side effects. Recent advances in asthma biology and in technology have provided exciting opportunities to improve personalized severe asthma management. Leveraging insights from the NHLBI Precise network and ICAN meeting, we will provide an update on the latest insights in this field.
• Apply home assessments to longitudinal asthma management
• Describe new findings regarding androgens and other sex steroids in asthma
• Describe new insights regarding the use of imaging in asthma
Anastasia Ivanova, PHD
Dawn Newcomb, PhD
Victor Ortega, MD, PhD, ATSF
Eleanor Dunican, BM BCH
Praveen Akuthota, MD, ATSF
Application of an Adaptive Trial Design to Severe Asthma Research
Androgens and Other Sex Hormones in Severe Asthma
Potential Use of Genetics and Biomarkers to Personalize Severe Asthma Management
Asthma Imaging: Novel Insights
Recent Advances in At-Home Assessments of Asthma Control